MedTrace Logo

Faecal Microbiota Analysis in Neurotypical and Autism Syndrome Disorder Siblings

NCT05794620 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2026-02-09

No results posted yet for this study

Summary

This study aims to accurately characterise the gut microbiota composition of faeces of children with ASD and compare it with the gut microbiota composition of their neurotypical siblings. In addition it aims to also characterise the metagenome and metabolome of the faeces of both ASD and neurotypical siblings.

Conditions

Interventions

OTHER

Stool sample

Stool sample

Sponsors & Collaborators

  • Quadram Institute Bioscience

    collaborator OTHER

  • East Suffolk and North Essex NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Ben Marlow · East Suffolk and North Essex NHS Foundation Trust

Eligibility

Min Age
3 Years
Max Age
10 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-12-20
Primary Completion
2024-04-08
Completion
2024-04-12

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05794620 on ClinicalTrials.gov